figshare
Browse
gr1.jpg (845.85 kB)

Figure 1: Body Weight, LV Mass, and Cardiac Function in Empagliflozin-Treated

Download (845.85 kB)
figure
posted on 2019-06-12, 08:29 authored by Subodh Verma, Sonia Rawat, Kim L. Ho, Cory S. Wagg, Liyan Zhang, Hwee Teoh, John E. Dyck, Golam M. Uddin, Gavin Y. Oudit, Eric Mayoux, Michael Lehrke, Nikolaus Marx, Gary D. Lopaschuk
Body weight (n = 16 to 19/group) (A) and ventricular mass measured after sacrifice (n = 12 to 13/group) (B) are shown. Cardiac work presented in J ∙ min−1 ∙ gram dry weight−1 (C) and cardiac output in ml ∙ min−1 (D) (n = 19 to 20/group) determined by isolated working heart perfusion are shown. Data are presented as mean ± SEM. Data were analyzed by 1-way analysis of variance (ANOVA) followed by least significant difference (LSD) post hoc test. Cardiac work and cardiac output were analyzed by repeated 1-way ANOVA followed by LSD post hoc test. *p < 0.05 was considered as a significantly different comparison with C57BL/6J + Vehicle. †p < 0.05 was considered as a significantly different comparison with db/db + Vehicle.

History

Usage metrics

    Journal of the American College of Cardiology

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC